Anti-aggregation therapy in patients with acute coronary syndrome — recommendations for medical emergency teams. Experts’ standpoint
- 15 September 2017
- journal article
- research article
- Published by Polskie Towarzystwo Kardiologiczne in Polish Heart Journal
- Vol. 75 (V) , 47-56
Abstract
No abstract availableThis publication has 47 references indexed in Scilit:
- Impact of morphine on antiplatelet effects of oral P2Y12 receptor inhibitorsInternational Journal of Cardiology, 2016
- Crushed Versus Integral Tablets of Ticagrelor in ST-Segment Elevation Myocardial Infarction Patients: A Randomized Pharmacokinetic/Pharmacodynamic StudyClinical Pharmacokinetics, 2015
- Intravenous morphine administration and reperfusion success in ST-elevation myocardial infarction: insights from cardiac magnetic resonance imagingClinical Research in Cardiology, 2015
- Time-related changes in determinants of antiplatelet effect of clopidogrel in patients after myocardial infarctionEuropean Journal of Pharmacology, 2014
- Comparison of Prasugrel and Ticagrelor Loading Doses in ST-Segment Elevation Myocardial Infarction PatientsJACC, 2013
- Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass SurgeryJACC, 2011
- ACCF/ACG/AHA 2010 Expert Consensus Document on the Concomitant Use of Proton Pump Inhibitors and Thienopyridines: A Focused Update of the ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID UseJACC, 2010
- Effect of Narcotic Treatment on Outcomes of Acute Coronary SyndromesThe American Journal of Cardiology, 2010
- Inhibition of Platelet Aggregation by AZD6140, A Reversible Oral P2Y12Receptor Antagonist, Compared With Clopidogrel in Patients With Acute Coronary SyndromesJACC, 2007
- Association of intravenous morphine use and outcomes in acute coronary syndromes: Results from the CRUSADE Quality Improvement InitiativeAmerican Heart Journal, 2005